Factors associated with glycemic control among diabetic adult out-patients in Northeast Ethiopia

BMC Research Notes
Temesgen FisehaAngesom Gebreweld

Abstract

The aim of this study was to determine the status of glycemic control and identify factors associated with poor glycemic control among diabetic out-patients. A hospital based cross-sectional study was conducted among randomly selected 384 (126 type 1 and 258 type 2) diabetic adults attending a hospital in Northeast Ethiopia from January 1 to April 30, 2017. Of the total participants, 70.8% had poor status of glycemic control (defined as mean fasting blood glucose level above 130 mg/dl). In the multivariate analysis, rural residence (AOR = 2.61, 95% CI 1.37-4.96), low educational level (AOR = 7.10, 95% CI 2.94-17.17) and longer duration of diabetes (AOR = 2.20, 95% CI 1.18-4.08) were significantly associated with increased odds of poor glycemic control. Moreover, merchants (AOR = 3.39, 95% CI 1.16-9.96) were significantly more likely to have poor glycemic control compared to government employee. Diabetic patients receiving oral anti-diabetics (AOR = 5.12, 95% CI 2.10-12.52) or insulin (AOR = 3.26, 95% CI 1.26-8.48) were more likely to be poorly controlled. These results highlight the needed for appropriate management of patients focusing on associated factors identified for poor glycemic control to maintain good glycemic control...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Nov 14, 2001·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·A LloydP Hopkinson
May 17, 2005·Revista de saúde pública·Maria Cecília F AssunçãoNeiva C J Valle
Dec 7, 2005·Clinical Therapeutics·Derek LeRoith, Deirdre O Smith
Jan 18, 2006·Cost Effectiveness and Resource Allocation : C/E·Alan K OglesbyMaureen J Lage
Dec 16, 2006·The Journal of Ambulatory Care Management·Douglas W RoblinEdmund R Becker
May 21, 2008·Annals of Internal Medicine·Kerri CavanaughRussell L Rothman
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Aug 24, 2011·Diabetes Management·Kerri L Cavanaugh
Oct 8, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·S MardenD Kerr
Mar 1, 2006·Indian Journal of Clinical Biochemistry : IJCB·Meena VermaP G Raman
Aug 16, 2014·Therapeutic Advances in Endocrinology and Metabolism·Hanan NoureddineMounzer Saleh
Feb 7, 2015·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Solomon Mekonnen AbebeNebiyu Mesfin
Jul 24, 2015·The Lancet. Diabetes & Endocrinology·Rifat Atun, Edwin A M Gale
Aug 25, 2015·The Lancet. Diabetes & Endocrinology
Mar 7, 2017·International Journal of General Medicine·Davis KibirigeWilliam Lumu

❮ Previous
Next ❯

Citations

Aug 28, 2019·PloS One·Eyob Alemayehu GebreyohannesSewunet Admasu Belachew
Jun 26, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Tadesse ShelemeTamiru Sahilu
Jan 1, 2020·Journal of Diabetes and Metabolic Disorders·Adane Teshome KefaleHabtamu Acho Addo
Jan 24, 2021·Diabetes & Metabolic Syndrome·Bayu Begashaw BekeleSeithikurippu R Pandi-Perumal
Mar 13, 2021·BioMed Research International·Luu Quang ThuyNguyen Hoang Thanh
Jul 23, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Tewodros YosefEyob Tekalign

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.